Utilizing triple quadrupole mass spectrometry to quantitate 106 drugs of abuse in urine

Importance of the Topic

Quantitative analysis of drugs of abuse in urine is critical for clinical and forensic toxicology due to rising global drug use and overdose rates. Reliable, high-throughput methods capable of detecting a wide chemical variety, including isomeric compounds at low concentration levels, ensure accurate case outcomes and timely patient care.

Objectives and Study Overview

The study aimed to develop and validate a single 7-minute LC-MS/MS workflow for confirmation and quantification of 106 commonly encountered drugs of abuse and their metabolites in human urine. Emphasis was placed on sensitivity, reproducibility, isomer separation, and ease of method expansion.

Methodology

Urine calibrators (0.1–5000 ng/mL) and internal standards were prepared in six mixtures. Samples (200 µL) underwent solid-phase extraction using mixed-mode SCX SPE plates with minimal solvent volumes. Eluates were analyzed by reversed-phase UHPLC on a 50 × 2.1 mm, 1.5 µm C18 column under a rapid 7 min gradient. The TSQ Quantis Plus triple quadrupole mass spectrometer operated in SRM mode at 600 SRM/s, applying polarity switching and dynamic exclusion to maximize dwell time. Data processing used TraceFinder software with predefined confirmation and quantitation criteria.

Applied Instrumentation

• Thermo Scientific Vanquish Horizon UHPLC system
• Thermo Scientific TSQ Quantis Plus triple quadrupole mass spectrometer
• Thermo Scientific SOLAµ SCX SPE plates (P/N 60209-002)
• Thermo Scientific TraceFinder 5.2 software

Main Results and Discussion

All 106 target analytes were baseline separated and quantified with calibration curves (R² > 0.99). LOQs ranged from 0.1 to 50 ng/mL, with 39 compounds achieving LOQs below 1 ng/mL—far exceeding common cutoff values. Key isomeric pairs (e.g., codeine/hydrocodone, morphine/hydromorphone) showed clear baseline resolution. The dynamic range extended up to 5000 ng/mL with robust linearity and confirmation ion ratios within ±20%.

Benefits and Practical Applications

• Rapid, single-run analysis enhances laboratory throughput.
• High sensitivity and reproducibility support low-level detections.
• Broad drug class coverage simplifies panel management.
• Flexible software database enables quick method customization.

Future Trends and Opportunities

Future directions include expanding analyte libraries to emerging synthetic compounds, integrating automated sample handling, coupling high-resolution MS for untargeted screening, and applying machine learning for data interpretation. Development of microflow or portable LC-MS platforms may further accelerate screening in field settings.

Conclusion

This validated 7-minute LC-MS/MS method delivers a comprehensive, high-throughput solution for quantifying 106 drugs of abuse in urine. Leveraging robust sample preparation, fast UHPLC separation, and sensitive triple quadrupole detection, the workflow meets stringent forensic and clinical requirements while remaining easily extensible.

References

• United Nations Office on Drugs and Crime: Special Points of Interest; 2023.
• Thermo Fisher Scientific Technical Note 74138: Evaluation of custom injection programs and larger internal diameter capillary for strong solvent sample effects mitigation in liquid chromatography; 2023.